Načítá se...

Post-transplant peripheral blood donor-specific IFN-γ ELISPOT assays differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients

Noninvasive diagnosis of kidney allograft inflammation in transplant recipients with stable graft function (subclinical rejection) could permit more effective therapy and prevent later development of de novo anti-donor HLA antibodies and/or graft dysfunction. Here we tested whether quantifying post-...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Kidney Int
Hlavní autoři: Crespo, Elena, Cravedi, Paolo, Martorell, Jaume, Luque, Sergi, Melilli, Edoardo, Cruzado, Josep M, Jarque, Marta, Meneghini, Maria, Manonelles, Anna, Donadei, Chiara, Lloberas, Núria, Gomà, Montse, Grinyó, Josep M, Heeger, Peter, Bestard, Oriol
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5930006/
https://ncbi.nlm.nih.gov/pubmed/28274484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2016.12.024
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!